NYX Nyse Euronext

NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for April 20101. Derivatives trading volumes in April 2010 recorded strong year-over-year growth, with European derivatives average daily volume (“ADV”) increasing 51.5%, driven in part by a 47% increase in fixed income derivatives product ADV and U.S. options ADV increasing 62%. Cash equities ADV was mixed with European cash trading volumes slightly below prior year levels while U.S. cash declined 26.6% versus prior year levels. U.S. and European cash trading volumes, however, were both up over 20% from March 2010 levels.

Highlights

• NYSE Euronext European derivatives products ADV in April 2010 of 6.8 million contracts increased 51.5% compared to April 2009 and increased 46.9% from March 2010 levels. Total European fixed income products ADV in April 2010 of 2.8 million contracts increased 46.5% compared to April 2009 and increased 4.7% from March 2010. Total equity products ADV of 4.0 million contracts in April 2010 increased 56.2% compared to April 2009 and increased 105.0% from March 2010.
• On April 28, 2010, NYSE Liffe set a new total exchange record for derivative contracts traded of 12.4 million contracts in a single day, 7% above the previous record of 11.6 million contracts recorded on December 18, 2008.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.0 million contracts in April 2010 increased 62.3% compared to April 2009 levels and increased 12.8% from March 2010. NYSE Euronext’s U.S. options exchanges accounted for 25.3% of the total consolidated equity options trading in April 2010, up from 17.0% in April 2009 and in line with the 25.3% recorded in March 2010.
• NYSE Euronext European cash products ADV of 1.6 million transactions in April 2010 decreased 0.2% compared to April 2009, but increased 22.2% from March 2010.
• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.9 billion shares in April 2010 decreased 26.6% compared to April 2009, but increased 21.4% compared to March 2010. NYSE Euronext matched share of all U.S. cash equity trading volume was 26.6% in April 2010, up from 25.6% in March 2010. NYSE Euronext’s Tape A matched market share in April 2010 was 34.1% up from 33.6% in March 2010.
• There were a total of 20 trading days in Europe and 21 days in the U.S. in both April 2010 and April 2009.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in April 2010 was 6.8 million futures and options contracts, an increase of 51.5% from April 2009 and an increase of 46.9% from March 2010. The 6.8 million in futures and options contracts ADV in April 2010 consisted of 3.9 million contracts executed through our full-service LIFFE CONNECT trading platform and 2.9 million contracts, or 42.0%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Year-to-date, European derivatives products ADV of 5.3 million contracts was 34.7% above prior year levels. The 5.3 million in futures and options contracts ADV year-to-date consisted of 3.9 million contracts executed through LIFFE CONNECT trading platform and 1.4 million contracts, or 26.8%, executed through Bclear.
• On April 28, 2010, NYSE Liffe set a new total exchange record for derivative contracts traded of 12.4 million contracts in a single day, 7% above the previous record of 11.6 million contracts recorded on December 18, 2008.
• Total fixed income products ADV of 2.8 million contracts in April 2010 increased 46.5% from April 2009 and increased 4.7% from March 2010. Year-to-date, total fixed income products ADV of 2.7 million contracts was 38.8% above prior year levels.
• Total equity products (including Bclear) ADV of 4.0 million contracts in April 2010 increased 56.2% compared to April 2009 and increased 105.0% from March 2010. The 4.0 million contracts in equity products ADV consisted of 3.4 million contracts in individual equity products ADV and 0.6 million contracts in equity index products ADV. The 3.4 million contracts in individual equity products ADV consisted of 2.6 million in futures contracts, which represented a 93.7% increase compared to April 2009 and 0.7 million in options contracts, which represented a 33.9% increase compared to April 2009. The rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.5 million contracts was 31.1% above prior year levels.
• Total commodities products ADV of 57,000 contracts in April 2010 increased 7.4% compared to April 2009 and increased 10.9% from March 2010. Year-to-date, total commodities product ADV of 53,000 contracts was 12.4% above prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.0 million contracts in April 2010 increased 62.3% compared to April 2009 and increased 12.8% compared to March 2010. Year-to-date, U.S. equity options ADV of 3.8 million contracts was 62.7% above prior year levels.
• Total U.S. consolidated equity options ADV increased 9.1% to 15.8 million contracts in April 2010 compared to April 2009 and increased 12.5% compared to March 2010. Year-to-date, U.S. consolidated equity options ADV of 14.4 million contracts was 7.2% above prior year levels.
• NYSE Euronext’s U.S. options exchanges accounted for 25.3% of the total consolidated equity options trading in April 2010, up from 17.0% in April 2009 and in-line with the 25.3% in March 2010.
• NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in April 2010 was approximately 19,000 contracts, compared to 18,000 contracts in March 2010. Year-to-date U.S. futures and futures options ADV was 20,000 contracts.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.6 million transactions in April 2010 decreased 0.2%, compared to April 2009, but increased 22.2% compared to March 2010. Year-to-date, European cash products ADV of 1.4 million transactions was 0.4% below prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in April 2010 decreased 26.6% to 2.9 billion shares compared to April 2009, but increased 21.4% from March 2010. Year-to-date, U.S. cash products handled ADV was 2.6 billion shares, down 34.3% from prior year levels.
• NYSE Euronext’s Tape A matched market share in April 2010 was 34.1%, up from 33.6% in March 2010.
• Designated Market Maker participation in April 2010 was 9.5%, compared to 8.5% in March 2010. Supplemental Liquidity Provider participation in April 2010 was 12.0%, compared to 11.4% in March 2010. DMM and SLP participation pertain only to trading on NYSE.

Exchange Traded Products

• NYSE Euronext U.S. matched exchange-traded products ADV (included in volumes for Tape B and Tape C) of 326 million shares in April 2010 decreased 42.8% compared to April 2009, but increased 19.9% compared to March 2010. Year-to-date, NYSE Euronext U.S. matched exchange-traded products ADV of 325 million shares was 45.9% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: http://www.nyx.com.

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext’s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext’s results to differ materially from current expectations include, but are not limited to: NYSE Euronext’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext’s reference document for 2009 ("document de référence") filed with the French Autorité des Marchés Financiers (Filed on April 22, 2010 under No. D.10-0304), 2009 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

1 All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

NYSE Euronext

Monthly Volume Summary - Derivatives Products

                          Average Daily Volume Total Volume Average Daily Volume Total Volume (Unaudited; contracts in thousands) Apr-10 Apr-09 % Chg Apr-10 Apr-09 % Chg YTD 2010

% Chg vs.YTD 2009

YTD 2010

% Chg vs.YTD 2009

  Number of Trading Days - European Markets 20 20 20 20 83 83 Number of Trading Days - U.S. Markets 21 21 21 21 82 82   European Derivatives Products 6,790 4,481 51.5% 135,805 89,628 51.5% 5,318 34.7% 441,411 34.7% of which Bclear 2,850 1,550 83.8% 56,995 31,003 83.8% 1,424 57.5% 118,229 57.5%   Total Fixed Income Products 2,753 1,879 46.5% 55,056 37,584 46.5% 2,721 38.8% 225,877 38.8%   Short Term Interest Rate Products 2,654 1,797 47.7% 53,089 35,945 47.7% 2,609 39.9% 216,507 39.9% Medium and Long Term Interest Rate Products 1 98 82 20.0% 1,968 1,639 20.0% 113 17.5% 9,370 17.5%   Total Equity Products 2 3,980 2,549 56.2% 79,599 50,974 56.2% 2,544 31.1% 211,112 31.1%   Individual Equity Products 3,385 1,932 75.2% 67,703 38,641 75.2% 1,928 49.5% 160,046 49.5% Futures 2,587 1,336 93.7% 51,747 26,721 93.7% 1,174 79.5% 97,459 79.5% Options 798 596 33.9% 15,956 11,919 33.9% 754 18.6% 62,587 18.6% Equity Index Products 595 617 -3.5% 11,896 12,334 -3.5% 615 -5.3% 51,066 -5.3%   of which Bclear 2,850 1,550 83.8% 56,995 31,003 83.8% 1,424 57.5% 118,229 57.5% Individual Equity Products 2,763 1,426 93.8% 55,266 28,511 93.8% 1,312 72.1% 108,901 72.1% Futures 2,587 1,301 98.8% 51,745 26,028 98.8% 1,173 83.1% 97,398 83.1%

Options

176 124 41.8% 3,522 2,483 41.8% 139 14.0% 11,503 14.0% Equity Index Products 86 125 -30.6% 1,729 2,491 -30.6% 112 -20.8% 9,329 -20.8%   Commodity Products 57 53 7.4% 1,149 1,070 7.4% 53 12.4% 4,422 12.4%   U.S. Derivatives Products   Equity Options 3   NYSE Group Options Contracts 4,010 2,470 62.3% 84,201 51,873 62.3% 3,789 62.7% 310,691 62.7% Total Consolidated Options Contracts 15,824 14,505 9.1% 332,306 304,600 9.1% 14,449 7.2% 1,184,807 7.2%   NYSE Group Share of Total 25.3% 17.0% 25.3% 17.0% 26.2% 8.9% 26.2% 8.9%   NYSE Liffe U.S.   Futures and Futures Options Volume 18.8 13.0 44.5% 395 273 44.5% 20.3 6.6% 1,662.8 6.6%       NYSE Euronext

Monthly Volume Summary - Cash Products

  Average Daily Volume Total Volume Average Daily Volume Total Volume (Unaudited) Apr-10 Apr-09 % Chg Apr-10 Apr-09 % Chg YTD 2010

% Chg vs.YTD 2009

YTD 2010

% Chg vs.YTD 2009

  Number of Trading Days - European Markets 20 20 20 20 83 83 Number of Trading Days - U.S. Markets 21 21 21 21 82 82   European Cash Products (trades in thousands) 1,580 1,583 -0.2% 31,602 31,658 -0.2% 1,420 -0.4% 117,826 -0.4%   Equities 1,520 1,515 0.3% 30,394 30,290 0.3% 1,363 0.3% 113,090 0.3% Exchange-Traded Funds 18 15 17.6% 364 310 17.6% 17 16.5% 1,376 16.5% Structured Products 36 47 -23.7% 715 938 -23.7% 34 -26.5% 2,831 -26.5% Bonds 6 6 6.2% 128 121 6.2% 6 14.1% 529 14.1%   U.S. Cash Products (shares in millions) 5 2,862 3,902 -26.6% 60,105 81,942 -26.6% 2,623 -34.3% 215,097 -34.3%   NYSE Listed (Tape A) Issues 4   NYSE Group Handled Volume 5 2,129 2,839 -25.0% 44,706 59,622 -25.0% 1,902 -34.5% 155,955 -34.5% NYSE Group Matched Volume 6 1,978 2,567 -22.9% 41,537 53,906 -22.9% 1,765 -32.8% 144,731 -32.8% Total NYSE Listed Consolidated Volume 5,796 6,538 -11.3% 121,721 137,300 -11.3% 5,104 -20.5% 418,539 -20.5%   NYSE Group Share of Total Consolidated Volume Handled Volume 5 36.7% 43.4% -6.7% 36.7% 43.4% -6.7% 37.3% -8.0% 37.3% -7.9% Matched Volume 6 34.1% 39.3% -5.2% 34.1% 39.3% -5.2% 34.6% -6.3% 34.6% -6.3%   NYSE Arca & Amex (Tape B) Listed Issues   NYSE Group Handled Volume 5 381 651 -41.5% 7,999 13,677 -41.5% 381 -43.6% 31,259 -43.6% NYSE Group Matched Volume 6 343 566 -39.4% 7,199 11,878 -39.4% 339 -42.9% 27,778 -42.9% Total NYSE Arca & Amex Listed Consolidated Volume 1,492 2,370 -37.0% 31,342 49,778 -37.0% 1,476 -37.6% 120,995 -37.6%   NYSE Group Share of Total Consolidated Volume Handled Volume 5 25.5% 27.5% -2.0% 25.5% 27.5% -2.0% 25.8% -2.8% 25.8% -2.8% Matched Volume 6 23.0% 23.9% -0.9% 23.0% 23.9% -0.9% 23.0% -2.1% 23.0% -2.1%   Nasdaq Listed (Tape C) Issues   NYSE Group Handled Volume 5 352 412 -14.4% 7,400 8,643 -14.4% 340 -18.2% 27,884 -18.2% NYSE Group Matched Volume 6 291 341 -14.8% 6,104 7,168 -14.8% 279 -19.0% 22,854 -19.0% Total Nasdaq Listed Consolidated Volume 2,525 2,347 7.5% 53,016 49,296 7.5% 2,387 5.5% 195,698 5.5%   NYSE Group Share of Total Consolidated Volume Handled Volume 5 14.0% 17.5% -3.5% 14.0% 17.5% -3.5% 14.2% -4.1% 14.2% -4.1% Matched Volume 6 11.5% 14.5% -3.0% 11.5% 14.5% -3.0% 11.7% -3.5% 11.7% -3.5%   Exchange-Traded Funds 5,7   NYSE Group Handled Volume 5 360 656 -45.0% 7,569 13,767 -45.0% 364 -46.7% 29,825 -46.7% NYSE Group Matched Volume 6 326 571 -42.8% 6,852 11,982 -42.8% 325 -45.9% 26,626 -45.9% Total ETF Consolidated Volume 1,433 2,439 -41.3% 30,091 51,220 -41.3% 1,440 -41.0% 118,108 -41.0%   NYSE Group Share of Total Consolidated Volume Handled Volume 5 25.2% 26.9% -1.7% 25.2% 26.9% -1.7% 25.3% -2.7% 25.3% -2.7% Matched Volume 6 22.8% 23.4% -0.6% 22.8% 23.4% -0.6% 22.5% -2.1% 22.5% -2.1%       1 Data includes currency products.

2

Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives. 3 Includes trading in U.S. equity options contracts, not equity-index options. 4 Includes all volume executed in NYSE Group crossing sessions. 5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. 6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. 7 Data included in previously identified categories. Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.